Voloridge Investment Management, LLC Axonics, Inc. Transaction History

Voloridge Investment Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $730,887 - $916,998	15,230 New	15,230 $768,000
Q1 2022 May 16, 2022	SELL	$43.74 - $62.76 $768,118 - $1.1 Million	-17,561 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$50.01 - $73.35 $12,102 - $17,750	-242 Reduced 1.36%	17,561 $983,000
Q3 2021 Nov 15, 2021	BUY	$59.21 - $78.66 $1.05 Million - $1.4 Million	17,803 New	17,803 $1.16 Million
Q2 2021 Aug 16, 2021	SELL	$51.39 - $66.9 $566,626 - $737,639	-11,026 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$49.14 - $59.89 $541,817 - $660,347	11,026 New	11,026 $660,000
Q4 2020 Feb 16, 2021	SELL	$42.19 - $51.5 $849,495 - $1.04 Million	-20,135 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$35.33 - $51.04 $711,369 - $1.03 Million	20,135 New	20,135 $1.03 Million
Q4 2019 Feb 14, 2020	SELL	$19.57 - $28.96 $220,651 - $326,524	-11,275 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$26.92 - $42.41 $303,523 - $478,172	11,275 New	11,275 $304,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.